Table 1.
Distribution of qualitative and quantitative variables among the 9792 male and female subjects, Fasa PERSIAN cohort study, 2014–2019
| Variable | Total | Female | Male | P-value |
|---|---|---|---|---|
| Age (years) | 48.74 ± 9.56 | 48.64 ± 9.53 | 48.86 ± 9.61 | 0.26 |
| DM | 12.4% | 16% | 7.9% | < 0.0001* |
| HTN | 20.3% | 27.2% | 11.6% | < 0.0001* |
| DBP (mmHg) | 74.71 ± 11.94 | 74.90 ± 12.05 | 74.47 ± 11.79 | 0.07 |
| SBP (mmHg) | 111.49 ± 18.46 | 112.09 ± 19.15 | 110.72 ± 17.51 | < 0.0001* |
| MAP (mmHg) | 86.96 ± 13.42 | 87.29 ± 13.74 | 86.55 ± 13.00 | 0.006* |
| BMI (Kg/m2) | 25.69 ± 4.82 | 26.85 ± 4.81 | 24.21 ± 4.41 | < 0.0001* |
| MET (ml/kg/min) | 41.41 ± 11.25 | 38.43 ± 6.72 | 45.22 ± 14.31 | < 0.0001* |
| WBC (count/µl) | 6.36 ± 1.34 | 6.32 ± 1.32 | 6.41 ± 1.36 | 0.002* |
| FBS (mg/dl) | 92.70 ± 29.59 | 94.56 ± 33.05 | 90.33 ± 24.28 | < 0.0001* |
| Triglyceride (mg/dl) | 131.57 ± 82.19 | 128.31 ± 74.23 | 135.73 ± 91.18 | < 0.0001* |
| Cholesterol (mg/dl) | 185.28 ± 39.13 | 190.28 ± 39.44 | 178.90 ± 37.78 | < 0.0001* |
| AlkP (IU/l) | 209.53 ± 71.65 | 208.24 ± 75.61 | 211.17 ± 66.23 | 0.04* |
| HDL (mg/dl) | 51.20 ± 15.96 | 54.17 ± 16.41 | 47.40 ± 14.51 | < 0.0001* |
| LDL (mg/dl) | 107.74 ± 32.82 | 110.41 ± 33.56 | 104.33 ± 31.53 | < 0.0001* |
| GGT (IU/l) | 22.80 ± 21.45 | 20.43 ± 20.06 | 25.81 ± 22.75 | < 0.0001* |
| Energy intake (kcal/day) | 2929.9 ± 1148.2 | 2819.9 ± 1113.5 | 3070.4 ± 1176.39 | < 0.0001* |
| FLI | 39.73 ± 27.72 | 43.49 ± 27.62 | 34.94 ± 27.11 | < 0.0001* |
| DII | -0.30 ± 2.05 | -0.26 ± 2.21 | -0.35 ± 1.83 | 0.03* |
| HT | 28.1% | 27.4% | 29.1% | 0.06 |
| HC | 32.3% | 36.6% | 26.8% | < 0.0001* |
| Opium consumption | 22% | 1.8% | 47.7% | < 0.0001* |
| Smoking | 25.9% | 5% | 52.5% | < 0.0001* |
| NAFLD | 26.9% | 30.9% | 21.8% | < 0.0001* |
| Total count | 9792 | 5494 | 4298 | - |
DM diabetes mellitus, HTN hypertension, NAFLD non-alcoholic fatty liver disease, DBP diastolic blood pressure, SBP systolic blood pressure, MAP mean arterial pressure, BMI body mass index, MET metabolic equivalent, WBC white blood cell, FBS fasting blood sugar, AlkP alkaline phosphatase, IU international unit, HDL high-density lipoprotein, LDL low-density lipoprotein, GGT gamma-glutamyl transferase, FLI fatty liver index, DII dietary inflammatory index. P-value ˂0.05 is considered significant. * indicates significance